[HTML][HTML] Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular …
Bioinformatics pipelines are an integral component of next-generation sequencing (NGS).
Processing raw sequence data to detect genomic alterations has significant impact on …
Processing raw sequence data to detect genomic alterations has significant impact on …
[HTML][HTML] Chronic granulomatous disease
D Roos - British medical bulletin, 2016 - ncbi.nlm.nih.gov
Introduction: Chronic granulomatous disease (CGD) is a primary immunodeficiency
characterized by recurrent, life-threatening bacterial and fungal infections of the skin, the …
characterized by recurrent, life-threatening bacterial and fungal infections of the skin, the …
[HTML][HTML] Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation …
The identification of specific genetic alterations as key oncogenic drivers and the
development of targeted therapies are together transforming clinical oncology and creating …
development of targeted therapies are together transforming clinical oncology and creating …
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications
Background Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic
CCA have diverse clinical presentations. Next generation sequencing (NGS) technology …
CCA have diverse clinical presentations. Next generation sequencing (NGS) technology …
HER2/neu-directed therapy for biliary tract cancer
Background Biliary cancers are highly aggressive tumors that are often diagnosed an
advanced disease stage and have a poor outcome with systemic therapy. Recent efforts …
advanced disease stage and have a poor outcome with systemic therapy. Recent efforts …
Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in …
RK Basho, M Gilcrease, RK Murthy, T Helgason… - JAMA …, 2017 - jamanetwork.com
Importance Triple-negative breast cancer (TNBC) classified by transcriptional profiling as the
mesenchymal subtype frequently harbors aberrations in the phosphoinositide 3-kinase …
mesenchymal subtype frequently harbors aberrations in the phosphoinositide 3-kinase …
Neoadjuvant BRAF-and immune-directed therapy for anaplastic thyroid carcinoma
ME Cabanillas, R Ferrarotto, AS Garden, S Ahmed… - Thyroid, 2018 - liebertpub.com
Anaplastic thyroid cancer (ATC) is a devastating disease with a dismal prognosis. Patients
who have disease confined to the thyroid and who are able to undergo complete surgery …
who have disease confined to the thyroid and who are able to undergo complete surgery …
Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease
CT Hiley, J Le Quesne, G Santis, R Sharpe… - The Lancet, 2016 - thelancet.com
Lung cancer diagnostics have progressed greatly in the previous decade. Development of
molecular testing to identify an increasing number of potentially clinically actionable genetic …
molecular testing to identify an increasing number of potentially clinically actionable genetic …
Impact of somatic mutations on survival outcomes in patients with anaplastic thyroid carcinoma
PURPOSE Anaplastic thyroid carcinoma (ATC) uniformly present with aggressive disease,
but the mutational landscape of tumors varies. We aimed to determine whether tumor …
but the mutational landscape of tumors varies. We aimed to determine whether tumor …
Expert opinion on NSCLC small specimen biomarker testing—Part 1: Tissue collection and management
F Penault-Llorca, KM Kerr, P Garrido, E Thunnissen… - Virchows Archiv, 2022 - Springer
Biomarker testing is crucial for treatment selection in advanced non-small cell lung cancer
(NSCLC). However, the quantity of available tissue often presents a key constraint for …
(NSCLC). However, the quantity of available tissue often presents a key constraint for …